Cybersecurity firm CounterTack has raised an additional $5M to bring their total Series B funding to $20M. The endpoint security player, who considers Mandiant (now FireEye owned Mandiant…) its biggest competitor will use this new funding to scale and expand their offerings.
Funding to Date: $34.5M ($14.5M Series A, $20M Series B)
Deal Notables: Two things of note on this round:
- This seemed to be a tranched round of some sort in that news clippings for this Series B go back as far as October 2013. We here at C:V. have never heard of a round having multiple closes of differing amounts over this long of a timeframe so we can only decipher that it was a tranche/milestone type round or that other investors were somehow able to get in at the B round price almost a year after the initial raise. Either way it seems the company is hitting on all cylinders and is well deserved of the additional funding to keep up with demand.
- The investors are a solid mix of future partners (Alcatel-Lucent), Private Investors (Fairhaven Capital Partners), and Public Investors (OnPoint Technologies – the US Army’s VC arm) and we really like to see when the OnPoint’s and In-Q-Tel’s of the world join in on investments to not only further the interests of national security but also help foster innovation in the security sector.